Trial Profile
Comparison between zotarolimus, everolimus, and sirolimus-eluting stent implantation in prevention of in-stent restenosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary) ; Zotarolimus (Primary)
- Indications Restenosis
- Focus Therapeutic Use
- 19 Dec 2015 New trial record